Zimbabwe has abruptly withdrawn from negotiations with the United States regarding a new health assistance package, a deal intended to replace a program previously dismantled during the Trump administration. The proposed agreement would have provided $367 million over five years to support 1.2 million Zimbabweans currently receiving HIV treatment.
Officials confirm that the talks were halted due to concerns that the terms of the pact threatened national autonomy. A key point of contention was the fear that the agreement would shift control of the country’s disease response strategies and grant Washington broad access to sensitive health data.
The United States has been pursuing similar bilateral health agreements across the African continent as part of its “America First” foreign policy strategy, which also aims to counter China’s growing influence in the region. Kenya, Rwanda, Uganda, Lesotho, and Eswatini are among the nations that have signed such deals.
With Zimbabwe stepping back from the negotiations, the US now faces the logistical challenge of winding down its health assistance programs in the country. The decision leaves the future of HIV treatment and broader health support for millions of Zimbabweans in a state of uncertainty.
